HOME >> BIOLOGY >> NEWS
Research into cetacean reproduction leads to birth of killer whales by artificial insemination

A systematic program of research into the reproductive physiology of killer whales by a team of scientists from SeaWorld, the National Zoological Park, and the Zoological Society of San Diego has culminated in the first live births of any cetacean--the group of marine mammals that includes whales and dolphins--by means of artificial insemination.

In a report set for publication in the journal Biology of Reproduction, the team, headed by Dr. Todd R. Robeck, based at SeaWorld San Antonio, notes that their research will allow sperm of killer whales in zoological facilities to be stored by a technique known as "genome resource banking" or GRB. GRB, used in conjunction with artificial insemination, could play an important role in ensuring the genetic vitality of captive marine mammals.

Robeck's team studied one male and five female killer whales to evaluate the reproductive physiology of these animals. The females were between 13 and 20 years old and weighed about 5,000 pounds. The male was 20 years old and weighed more than 11,000 pounds. All were trained to cooperate in a variety of procedures involved in the research.

Noninvasive techniques were used to collect data on reproductive hormonal patterns of the killer whale, and ultrasound exams helped establish the time of ovulation.

Semen collected from the male orca for use in the artificial insemination trials was either liquid-stored for up to three days or preserved by freezing and later thawed.

Eight attempts at artificial insemination over the course of two years led to three pregnancies, one from thawed sperm and two from liquid-stored sperm. One male calf and one female calf were born. The third pregnant female, who died of unrelated causes, was carrying a male fetus. Paternity tests confirmed that all three calves resulted from artificial insemination.

Although killer whales are common throughout the oceans of the world, the population in zoological facili
'"/>

Contact: Dr. Todd R. Robeck
Todd.Robeck@SeaWorld.com
Society for the Study of Reproduction
12-May-2004


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. Researchers identify protein promoting vascular tumor growth
5. Researchers devise potent new tools to curb ivory poaching
6. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
7. Researchers ID chlorophyll-regulating gene
8. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
9. Research suggests new avenue for stopping, preventing colon cancer
10. Researchers develop fast track way to discover how cells are regulated
11. Research on carbohydrate metabolism receives historical recognition

Post Your Comments:
(Date:6/17/2013)... On June 6, professors in Wayne State ... National Science Foundation-funded (NSF) Research Experience for Undergraduates ... an opportunity to do cutting-edge research in astrophysics, ... According to Alexey Petrov, Ph.D., professor of physics ... principal investigator and program director of the grant, ...
(Date:6/17/2013)... a sugar alcohol produced by fungi, bacteria, and algae, ... The sweetener is also used in the medical field ... to flush out excess fluids and used during surgery ... ease the passage of other drugs. , Now Profs. ... Department of Molecular Microbiology and Biotechnology and the Sagol ...
(Date:6/17/2013)... method of mining shale gas, is widespread across Pennsylvania, ... New research in the Annals of the New ... to biodiversity including pollution from toxic chemicals, the building ... , "Shale gas has engendered a great deal of ... but effects on biological diversity and resources have scarcely ...
Breaking Biology News(10 mins):Wayne State welcomes undergraduates from around the US for physics research experience 2Artificial sweetener a potential treatment for Parkinson's disease 2
(Date:6/17/2013)... , June 17, 2013 /PRNewswire-iReach/ -- The ... Bob Riedford , President/Founder of Riedford Management, Inc. to its ... as a member of the Chamber,s Board of Advisors," said ... "This is one of the most prestigious positions to hold ... and experience our new board members will contribute." ...
(Date:6/16/2013)... This training is ideal for those who ... the software industry or those who want to explore Agile ... , The topics that will be covered in the 1-day ... meetings, scrum artifacts, and scrum simulation (optional). , The ... CO June 28, 2013 , Click here to register for ...
(Date:6/14/2013)... , June 14, 2013  Royalty Pharma notes today,s ... that it intends to explore a sale of the Company. ... that offers shareholders no certainty that a deal will ever be ... vote today AGAINST all four resolutions up for ... to preserve Royalty Pharma,s formal offer for Elan. In ...
(Date:6/14/2013)... The OpenClinica Global Conference is being ... with Formedix CEO, Mark Wheeldon presenting as part of ... deeper insight into the future developments at OpenClinica and ... to develop innovative solutions. , The conference program will ... hear real-life case studies and discover more about best ...
Breaking Biology Technology:Raleigh Chamber Names Bob Riedford to Board of Advisors 2Affordable Scrum Trainings in Denver, CO – 8 PDUs (June 28, 2013) by Conscires Agile Practices 2Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 2Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 3Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 4Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 5Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 6Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 7Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 8Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 9Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 10Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 11Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 2Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 3
Cached News: